Plasma S100β is a predictor for pathology and cognitive decline in Alzheimer’s disease
Abstract Background Blood–brain barrier dysfunction is one characteristic of Alzheimer’s disease (AD) and is recognized as both a cause and consequence of the pathological cascade leading to cognitive decline. The goal of this study was to assess markers for barrier dysfunction in postmortem tissue...
Saved in:
Main Authors: | Geetika Nehra, Bryan J. Maloney, Rebecca R. Smith, Wijitra Chumboatong, Erin L. Abner, Peter T. Nelson, Björn Bauer, Anika M. S. Hartz |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2025-01-01
|
Series: | Fluids and Barriers of the CNS |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12987-024-00615-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Cerebrospinal fluid β2-microglobulin promotes the tau pathology through microglia–astrocyte communication in Alzheimer's disease
by: Zehu Sheng, et al.
Published: (2025-01-01) -
Comparison of single-point insulin sensitivity estimator (SPISE) index and cognitive performance in vitamin B12-deficient young adults: An analytical cross-sectional study
by: Himanshi Suri, et al.
Published: (2024-12-01) -
Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis
by: Jinwang Ye, et al.
Published: (2025-01-01) -
Rotation errors in path integration are associated with Alzheimer’s disease tau pathology: a cross-sectional study
by: Lise Colmant, et al.
Published: (2025-02-01) -
C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
by: Xiaoting Luo, et al.
Published: (2025-02-01)